AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Financial Times Signals a New Global Map for AI Drug Discovery
The Financial Times’ framing of Lilly’s deal with a Hong Kong biotech reflects a growing geographic decentralization in AI-enabled biopharma innovation. Cross-border partnerships are increasingly becoming the norm as pharma looks globally for computational and translational advantage.
Lilly’s Hong Kong AI Biotech Deal Highlights the Globalization of Drug Discovery Partnerships
The Financial Times reports Eli Lilly is signing a multibillion-dollar AI drug development deal with a Hong Kong biotech, underscoring how geographic boundaries in pharmaceutical innovation are fading. The significance is not just the size of the agreement, but the normalization of cross-border AI sourcing as a mainstream R&D strategy.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.